Comparison · updated October 27, 2026

Direct Meds GLP-1 vs Embody: Costs, care and treatment fit

Direct Meds GLP-1 and Embody differ in what you pay and which medicines they list. Compounded medicines are not FDA-approved.

Both are starting prices, so the plans below show what you would actually pay.

Compare plans and terms

Direct Meds GLP-1 and Embody pay us a commission when you join through our links. That never changes a score, an order or a fact on this page. How we make money

Which should you choose, Direct Meds GLP-1 or Embody?

Short answer: Choose Direct Meds GLP-1 if you want a pill or another option without needles. If that doesn't matter to you, compare their plans below.

Choose Direct Meds GLP-1 if

  • you want a pill or another option without needles
  • you put weight on customer ratings (4.6 on Trustpilot against 3.8)

Embody is best for

People comfortable prepaying a yearly compounded-injection plan who want to compare its full cost with a smaller one-month commitment.

The available assessments do not establish a score winner, so choose by the medicine, total cost and care you need.

By Iacob Pastina, Independent Researcher & Publisher
Reviewed & updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

Direct Meds GLP-1 vs Embody side by side

Direct Meds GLP-1 and Embody compared fact by fact
Direct Meds GLP-1Embody
Pricefrom $297/mofrom $49/mo
MedicineBothCompounded only
Needle-free optionYes, a pill or other oral formNot listed
InsuranceBothNo insurance listed
ConsultationBothIncluded
ShippingBothFree
Where it ships48 states plus Washington DC, not Mississippi or Louisiana49 states plus DC, all except Louisiana
Trustpilot4.6 / 5 across 16,278 reviews3.8 / 5 across 10,100 reviews
BBB ratingNot Rated (not accredited; October 9, 2026)D+ (not accredited)
Our score7.5/10 Good7.6/10 Good
Assessment limitsChecked Oct 16, 2026.Checked Oct 16, 2026; a rating claim didn't match Trustpilot.

What Direct Meds GLP-1 and Embody plans cost

Direct Meds GLP-1

Separate injection and sublingual-drop options, with provider review, nursing support and shipping included. Online intake does not establish better or worse clinical care than another program.

All 4 Direct Meds GLP-1 plans

We checked Direct Meds GLP-1's prices on September 3, 2026.

Embody

Four published plan lengths for each injection. A sale advertised October 27 through December 1, 2026 cut the twelve-month prepaid amounts to $588 for semaglutide and $1,188 for tirzepatide; one-month plans stayed at $79 and $129.

All 8 Embody plans

Payments are normally non-refundable; a limited medical-disqualification exception applies.

How Embody bills

The October 27–December 1, 2026 sale offers semaglutide at $49/month equivalent ($588 prepaid for twelve months) and tirzepatide at $99/month equivalent ($1,188 prepaid). One-month plans remain $79 and $129. The published terms say the rate stays fixed on the selected plan. Confirm the renewal amount and date before paying; these sale rates are not month-to-month bills.

We checked Embody's prices on October 27, 2026.Every Embody price and plan

Embody’s GLP-1 website is joinem.co. GLP-1 Picks is an independent comparison site.

Want Embody on its own? Read our Embody GLP-1 review to see what you pay for semaglutide or tirzepatide and what customer reviews say, or check is Embody legit for its BBB, Trustpilot and FDA records.

What to watch for with Direct Meds GLP-1 and Embody

Direct Meds GLP-1

  • Compounded medications only, no brand-name Wegovy, Zepbound, or Ozempic on the menu
  • Injectable compounded semaglutide is $297 a month and the sublingual drops are $249 a month on the product page, so the cheaper in-house format saves $48, and both sit above the lowest cash-pay entry prices in this comparison
Direct Meds GLP-1's strengths, cautions and terms

Strengths

  • The published $297/mo compounded semaglutide injection tier includes medication, consultations, shipping, and pharmacy fees
  • Format-specific prices are published on the site, which makes the advertised medication and service bundle easier to compare
  • Its executive team identifies Dr. Justin Hohl as chief medical officer
  • Ongoing nursing access and digital follow-ups are described in the program bundle

More to watch for

  • The marketing page says no subscriptions, but the terms cover automatic 30-day renewals for subscription products. Confirm which terms apply and the 48-hour cancellation cutoff
Medicines listed
  • Semaglutide (compounded injectable)
  • Semaglutide (sublingual drops, $249/mo)
  • Tirzepatide (compounded injectable)
  • Tirzepatide (sublingual drops, $299/mo)
  • NAD+ (non-GLP-1 wellness)
  • Sermorelin (non-GLP-1 peptide)
Insurance
No insurance support listed
Consultation
Included
Shipping
Free
States
48 states plus Washington DC, not Mississippi or Louisiana
Cancellation
For subscription products, turn off auto-refill at least 48 hours before the next processing date; terms specify 30-day billing with 5-7 days' advance notice. An order cancellation can be attempted within 24 hours only if the provider network has not received it. Received medication is non-refundable. Limited return exceptions apply, with a $35 disposal fee; report issues within 48 hours of receipt.

Embody

  • Payments are normally non-refundable. If Embody's provider determines medical disqualification, its refund policy allows a refund for unused services after deducting services already provided. Cancellation otherwise stops future renewal. During the sale advertised through December 1, 2026, the twelve-month semaglutide plan committed $588 up front; cancellation requests must reach support at least 72 hours before the next billing date.
  • The $49/$99 sale rates, advertised through December 1, 2026, required twelve-month prepayment of $588/$1,188 rather than monthly payments. Confirm any current price, the renewal amount and its date for your selected plan before paying.
Embody's strengths, cautions and terms

Strengths

  • The October 27, 2026 catalogue published four price tiers for each molecule: semaglutide $79/$76/$73/$49 and tirzepatide $129/$126/$123/$99 across one, three, six and twelve months. The twelve-month prices were a sale advertised through December 1, 2026, paid up front.
  • One-month injection prices of $79 for semaglutide and $129 for GLP-1 + GIP were visible in Embody's catalogue on September 20, 2026. The FAQ says the selected rate holds within the chosen plan.
  • Four plan lengths are disclosed (4, 12, 24 and 52 weeks), giving shoppers a shorter-term option as well as longer-plan pricing.
  • Publishes its cancellation and refund terms in full, dated August 25, 2026, so the 72-hour cancellation cutoff and limited medical-disqualification refund exception are readable before you pay.
  • Publishes responses to customer reviews on Trustpilot, giving readers the company's reply alongside individual complaints.

More to watch for

  • Trustpilot showed 3.8 / 5 across 10,100 reviews on October 17, 2026, while the landing page advertised 4.8 on our prior check. The Trustpilot profile includes merged reviews from another profile, and individual reports cover different pricing periods. It is not a measure of clinical quality.
  • Embody names four partner pharmacies: Red Rock Compounding Pharmacy in Utah, Health Warehouse in Kentucky, Precision Medicine in New York and Triad Rx in Alabama, and says all four are 503A compounding pharmacies. It does not say which one will fill your prescription. Triad Rx received a 2019 FDA warning letter for sterile-production violations, and the FDA close-out in May 2023 records that the firm no longer produces sterile drug products.
  • Embody's public catalogue lists only compounded injections; it doesn't list branded Wegovy, Zepbound, Mounjaro or Ozempic.
  • Modern Metabolic Medicine, Inc. also runs SnagRx (snagrx.com) and RodeoMeds (rodeomeds.com). Each footer names the shared parent, but none of the three names the others. Embody's October 27 catalogue listed a yearly-plan sale, advertised through December 1, 2026, with $49 semaglutide and $99 tirzepatide monthly equivalents; SnagRx has its own prices and payment terms. Read our SnagRx review, then compare Embody and SnagRx side by side.
Medicines listed
  • Compounded semaglutide (injectable)
  • Compounded tirzepatide (injectable)
Insurance
No insurance support listed
Consultation
Included
Shipping
Free
Prescribers
OpenLoop Health clinical network (individual credentials MD/NP/PA not publicly listed before signup)
Lab work
Not disclosed
States
49 states plus DC, all except Louisiana. In Nebraska, service is limited to patients 19 and older (verified 2026-09-03)
Cancellation
Choose a monthly, 3-, 6- or 12-month plan at signup. Cancellation requests must reach support at least 72 hours before the next billing date, and the policy dated August 25, 2026 says all payments are final and non-refundable, with a refund for unused services on provider-determined medical disqualification, after deductions for services already provided. Multi-month plans are non-refundable in whole and in part.

Compounded medicines are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before they are sold. Read the FDA's explanation of the risks.

Direct Meds GLP-1 vs Embody: common questions

Is Direct Meds GLP-1 or Embody cheaper?

At least one headline price is a starting, introductory, prepaid or partial figure, so neither is simply cheaper.

  • Direct Meds GLP-1from $297/mostarting price
  • Embodyfrom $49/mostarting price

Which is better, Direct Meds GLP-1 or Embody?

Neither wins outright on our scores, so the better one is the one that fits your medicine, budget and care needs.

Do Direct Meds GLP-1 and Embody offer brand-name medication?

Direct Meds GLP-1 and Embody both list compounded medication.

Compounded medications are not FDA-approved. Your prescriber decides which medicine suits you.

Do Direct Meds GLP-1 and Embody take insurance?

Neither Direct Meds GLP-1 nor Embody lists insurance support.

Where these facts come from

Direct Meds GLP-1:prices checked September 3, 2026, score evidence assessed October 16, 2026.Read our Direct Meds GLP-1 review

Embody:prices checked October 27, 2026, score evidence assessed October 16, 2026.Read our Embody review

We score on a published methodology, and partnership never changes a score or a fact here.

What should you compare next?